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Confounding or Cause and
Effect? 
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Main et al. (2007) reported that elevated
levels of polybrominated diphenyl ethers
(PBDEs) in breast milk, but not placenta,
were associated with congenital cryp-
torchidism in Danish and Finnish boys. For
the Danish cohort, the researchers used a
case–cohort design in which biological sam-
ples were collected from all study partici-
pants, whereas for the Finnish cohort, they
used a nested case–control design. The
matching criteria used for Finnish mothers
who gave birth to boys with cryptorchidism
(measured at birth) and matched Finnish
controls included the following: parity,
smoking (yes/no), diabetes (yes/no), gesta-
tional age (± 7 days), and date of birth
(± 14 days). However, Main et al. (2007)
did not provide information on adjust-
ments made to account for the type/severity
of diabetes (Virtanen et al. 2006), smoking
habits (Kurahashi et al. 2005), alcohol con-
sumption (Damgaard et al. 2007), cesarean
section (Hjertkvist et al. 1989; Kurahashi
et al. 2005), and other factors that may be
associated with cryptorchidism. 
Interestingly, Main et al. did note that
approximately 12% and 18% of breast milk
samples and placentas, respectively, were
obtained from diabetic Finnish mothers of
cryptorchid boys, compared with 0% of con-
trols (Main et al. 2007), but they conducted
no further inquiry on this discrepancy.
Damgaard et al. (2007) previously evaluated
this same Danish–Finnish cohort and
adjusted for confounders and effect modi-
fiers for differences observed based on coun-
try, smoking, caffeine intake, alcohol
consumption (including binge-drinking
episodes), social class, maternal age, parity,
maturity, and birth weight. Damgaard et al.
(2007) noted an association between mater-
nal alcohol consumption (≥ 5 drinks/week)
and transient cryptorchidism. Despite these
findings, Main et al. (2007) provided no
information on stratified alcohol consump-
tion or other potential confounders, such as
caffeine intake or social class.
Main et al. (2007) concluded that an
association exists between PBDE levels in
breast milk and cryptorchidism in boys, but
we should be cautious of this interpretation,
given that Main et al. (2007) may not have
adequately addressed potential confounders. 
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PBDEs and Cryptorchidism:
Main et al. Respond
doi:10.1289/ehp.11052R
In their letter, Banasik et al. emphasize that
the etiology of cryptorchidism may be multi-
factorial, and we agree. As stated in the
“Discussion” of our article (Main et al.
2007), exposure to environmental chemicals
is only one of many adverse factors that
alone, or in combination with each other,
may cause testicular maldescent. In turn,
lifestyle factors such as smoking and drinking
of alcohol may be interrelated, and a certain
lifestyle may augment the risk of exposure to
endocrine-disrupting chemicals. Genetic fac-
tors, complex medical syndromes, and
lifestyle factors have been previously identi-
fied as risk factors for cryptorchidism, but a
significant proportion of cryptorchidism
cases still remains unexplained (Virtanen
et al. 2007). 
In our study (Main et al. 2007) we found
an association between the level of poly-
brominated diphenyl ethers (PBDEs) in
breast milk and congenital cryptorchidism.
We reported that this remained significant
after adjusting for other well-known risk fac-
tors for cryptorchidism, such as premature
birth or low birth weight for gestational age
(Main et al. 2007), as well as adjusting for
maternal age, maternal prepregnancy body
mass index, parity, and date of childbirth
within the cohort, which may affect the level
of compounds found in breast milk samples
(Main et al. 2007). In the analysis of the
entire Danish–Finnish binational cohort,
other novel risk factors for cryptorchidism,
such as regular maternal alcohol consump-
tion during pregnancy and mild diabetes,
were identified (Damgaard et al. 2007;
(Virtanen et al. 2006). 
We originally decided against including
additional confounders in our analysis (Main
et al. 2007), considering the size of our study
group and thus the low number of cases for
each confounder, which induces a potential
risk of both false-positive and false-negative
results (Table 1). However, in a binary logis-
tic regression analysis including all con-
founders, as suggested by Banasik et al., the
association between the level of the seven
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Table 1. Additional characteristics (number) of the study population who provided breast milk samples.
Denmark Finland
Control Cryptorchid Control Cryptorchid
Characteristic (n = 36) (n = 29) (n = 32) (n = 33)
Delivery type
Vaginal delivery  28  16 26  23
Vacuum extraction  6  6 2 4
Cesarean section  2  7 4  4
Alcohol comsumption (drinks/week)
0 13 16 26  27
1–4 20 9 6  6
≥ 53 4 0  0
Alcohol binge-drinking episodes 
Yes 2 2 2 0
No 33 25 28 29
Social class
High- and low-grade professionals 20 16 17 21
Skilled and unskilled workers 9 7 9 6
Students and unemployed  7 6 6 5
Missing data were treated as missing values in the statistical analysis.most prevalent PBDEs (BDEs 28, 47, 66,
99, 100, 153, and 154) and congenital cryp-
torchidism remained significant (p < 0.039).
Confounders included maternal age, mater-
nal prepregnancy body mass index, gesta-
tional age, and weight for gestational age
included as continuous variables; parity (1 vs.
2 vs. ≥ 3), country of origin (Denmark/
Finland), social class (high- and low-grade
professionals vs. skilled and unskilled work-
ers vs. students and unemployed), smoking
(yes/no), diabetes (yes/no), binge episodes
(yes/no), and alcohol consumption (0 vs.
1–4 vs. ≥ 5 drinks/week) were entered as cat-
egorical factors, as described by Damgaard
et al. (2007).
In conclusion, the association between
perinatal exposure to PBDEs and congenital
cryptorchidism was significant even after
controlling for confounding factors. Our
study could not determine whether a direct
causal relationship exists or whether other
factors contribute to our findings. Because
the exposure to PBDEs is still considerable in
some areas, our results should raise concern
and stimulate further investigations of
human populations.
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Cryptorchidism: Effects of
Maternal Diabetes or PBDEs
doi:10.1289/ehp.11096
It was with great interest that we read the
article by Main et al. (2007) regarding poly-
brominated diphenyl ethers (PBDEs) and
cryptochordism, and we are impressed with
the data in humans. Main et al. stated that
the concentration of PBDEs in breast milk
was significantly higher in boys with cryp-
torchidism compared with controls. It is cer-
tainly possible that there is a link between
fetal PBDE exposure and cryptorchidism;
however, we noted that the cohort included
children of diabetic mothers. Of the 33 boys
with cryptorchidism, 4 in the Finnish group
and 1 of 28 in the Danish breast milk–
sample group had diabetic mothers. It is
widely known that diabetes is a major cause
of congenital malformations, and these mal-
formations are dependent on the severity of
the diabetes. Therefore, you cannot simply
match by diabetes between cases and con-
trols. In a study of 173 mothers with dia-
betes, we found that 10% of the offspring
had congenital malformations related to the
severity of the diabetes, classified according
to the Priscilla White classification (Koppe
et al. 1983). Virtanen et al. (2006), together
with Main, published a study reporting an
increased risk of cryptorchidism following
mild gestational diabetes. In our opinion,
the cases of mothers with diabetes should be
excluded from analysis of congenital mal-
formations, both in the breast milk group
and the placenta group reported by Main
et al. (2007).
The group of mothers with diabetes is in
itself an interesting group. Are the placenta
and breast milk levels of PBDEs or the fat
content different between the diabetic cases
and the others? 
In general, because most PBDEs have
phenobarbital-like effects, it seems plausible
that they should cause an increase in con-
genital malformations, such as is seen with
phenobarbital (Dessens et al. 1994; Koppe
et al. 1973).
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Respond
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ten Tusscher and Koppe point out that mater-
nal diabetes increases the risk of malforma-
tions in newborns and suggest that we should
have excluded diabetic mothers from the data
set. We agree with them that maternal dia-
betes increases the risk of congenital malfor-
mations, although there is only limited
evidence for this in the case of cryptorchidism.
In our large mother–child cohort from which
this data set was derived, we found a signifi-
cant association between gestational diabetes
and congenital cryptorchidism (Virtanen et al.
2006). 
We did not initially carry out an analysis
corrected for diabetes because the biological
samples were not selected with regard to dia-
betes; therefore data were potentially skewed
for this outcome. For the same reason, the
total number of mothers with diabetes in each
country was low in this data set. 
We have now reanalyzed the data, omit-
ting the mothers with diabetes (2 Danish and
4 Finnish mothers for breast milk samples,
and 2 Danish and 10 Finnish mothers for pla-
centas). In a binary logistic regression analysis
including all relevant confounders (maternal
age, maternal prepregnancy body mass index,
gestational age, weight for gestational age, par-
ity, and country of origin), the association
between the level of the seven most prevalent
polybrominated biphenyl ethers (PBDEs) in
breast milk (BDEs 28, 47, 66, 99, 100, 153,
and 154) and congenital cryptorchidism
remained significant (p < 0.032), with a
median level (2.5th–97.5th percentiles) of
3.16 ng/g fat (1.08–21.73) in controls and
4.19 ng/g fat (1.42–52.64) in cryptorchid
boys. The same analysis for the five most
prevalent BDEs in placenta (BDEs 47, 153,
99, 100, and 28) remained nonsignificant
(p = 0.173), with 1.23 ng/g fat (0.56–5.46) in
controls and 1.12 ng/g fat (0.37–4.24) in
cryptorchid boys.
ten Tusscher and Koppe also suggest the
investigation of potential differences between
mothers with and without diabetes with respect
to fat content in the samples and the concen-
trations of PBDEs. We previously reported
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Correspondencethat the lipid content in breast milk and pla-
centa was higher in Finnish than in Danish
samples (Shen et al. 2007). Country of origin
was therefore included as a covariate in a
binary logistic regression. We found no signif-
icant difference between mothers with and
without diabetes for fat content in breast milk
or placenta (p = 0.975 and 0.107, respec-
tively) or the sum of the most prevalent BDE
congeners (p = 0.233 and 0.317, respectively).
However, the number of diabetic mothers in
our data set is too small to draw any firm con-
clusions from these results.
In conclusion, the association between
perinatal exposure to PBDEs and congenital
cryptorchidism was significant after exclu-
sion of diabetic mothers. Exposure to envi-
ronmental chemicals is, however, one of
many adverse factors that alone, or in com-
bination with each other, may cause testicu-
lar maldescent (Main et al. 2007). These
additional factors include gestational compli-
cations, lifestyle, and genetic factors
(Virtanen et al. 2007). 
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Tungsten and Cobalt in Fallon,
Nevada: Association with
Childhood Leukemia
doi:10.1289/ehp.10614
In their article, Sheppard et al. (2007) sug-
gested that the “results in Fallon [Nevada] sug-
gest a temporal correspondence between the
onset of excessive childhood leukemia and ele-
vated levels of tungsten and cobalt.” Although
the authors reported some interesting findings
from their dendrochemistry (tree ring) analysis,
the results, as presented, do not support their
conclusion. In fact, if the data they report
demonstrate anything, it is that the levels of
tungsten in the environment are not causally
associated with the cases of leukemia. 
Sheppard et al.’s (2007) primary premise is
that levels of tungsten increased in Fallon rela-
tive to selected comparison towns beginning in
the mid-1990s, which the authors contend
predates the “1997 onset” of the increased inci-
dence of acute lymphocytic leukemia (ALL) in
Churchill County. In fact, when the appropri-
ate comparison is made, the data of Sheppard
et al. show that the purported increase in envi-
ronmental tungsten in Fallon occurred long
after the onset of these leukemia cases (i.e.,
after 2001). Thus, the data they gathered sup-
ports the conclusion of the Agency for Toxic
Substances and Disease Registry (2003) that
the evidence does not support any link
between tungsten and these leukemia cases. 
Unfortunately, Sheppard et al. (2007)
did not provide the actual data in their arti-
cle, and they did not include error bars or
standard deviations for the data points.
Regardless of these defects in data presenta-
tion, careful interpretation of the graphic rep-
resentations of the data yields several
important insights [the tungsten concentra-
tions listed here are approximate and were
obtained from interpolation of the data
points from the figures of Sheppard et al.
(2007)]. 
First, tree ring tungsten concentrations in
Fallon cottonwoods ranged from 40 to
70 ppm between 1989 and 2000, and then
increased to 180 ppm in the 2001–2004 time
period. Sweet Home, Oregon, cottonwoods
followed a similar pattern, ranging from 50 to
75 ppm between 1989 and 2000 and increas-
ing to 110 ppm for the 2001–2004 period.
Thus, no significant increase in tungsten in
cottonwood tree rings was observed at either
location until the 2001–2004 period, well after
the “onset” of the leukemia cases; 12 of the
15 leukemia cases (80%) had been diagnosed
by the end of 2000 [Centers for Disease
Control and Prevention (CDC) 2003]. 
Second, it appears that the “comparison
town” data comprise the Douglas-fir data
from Crawfordsville, Oregon, and data on
Douglas-firs and cottonwoods from Sweet
Home. Sheppard et al. (2007) acknowledged
that “temporal variability of tungsten is higher
in the cottonwoods than in the Douglas-firs,”
and Douglas-firs exhibit “damped temporal
variability.” This is likely to be at least par-
tially due to physiologic differences of tree
species (Sheppard et al. 2007). Comparing
tungsten levels in responsive cottonwoods in
Fallon to groups of trees from comparison
towns that included less responsive Douglas-
firs is an “apples-to-oranges” comparison, and
any differences are more likely related to the
differences in tree species than to different lev-
els of environmental tungsten. This uncer-
tainty is further exacerbated by comparing
trees from vastly different environments—the
temperate, agricultural areas of northwestern
Oregon and the high desert of western
Nevada.
Third, Sweet Home cottonwoods exhib-
ited an average of 62 ppm tungsten between
1989 and 2000. Fallon cottonwoods had an
average of 60 ppm during this same period.
The purported temporal variability between
the two locations is nonexistent when like
species are compared.
Finally, according to Sheppard et al.
(2007), the 1989–1996 period represents two
time periods that “predate the 1997 onset of
excessive leukemia ….” Yet, compared with
those in Fallon, the Sweet Home cottonwoods
exhibited slightly higher tungsten concentra-
tions over the 1989–1996 period. Thus,
according to the data of Sheppard et al. (2007),
environmental tungsten was actually lower in
Fallon than in Sweet Home during the period
leading up to the diagnosis of the Fallon
leukemia cases.
In summary, a critical evaluation of the data
leads to a radically different conclusion than
that presented by Sheppard et al. (2007).
Assuming that the data presented in the article
are correct and reflective of environmental con-
ditions in the Fallon area, the data indicate that
the purported increase in tungsten levels (if in
fact any increase occurred) occurred well after
the “onset of the excessive childhood leukemia”
and was not unique to this town. This inter-
pretation is consistent with, and further sup-
ports, the conclusions that tungsten was not
associated with the ALL cluster reached by the
CDC in their Cross-Sectional Exposure
Assessment in Fallon (CDC 2003; Rubin et al.
2007).
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Tungsten and Cobalt: Sheppard
et al. Respond
doi:10.1289/ehp.10614R
First and foremost, our data from Nevada
(Sheppard et al. 2007c) should not be quanti-
tatively compared with that from Oregon. We
did not make such a comparison in our article;
to reinforce separation of these two studies, we
described the results in separate subsections
and presented data in separate figures. Our
Oregon study was an independent test of
dendrochemistry for establishing temporal
patterns of environmental tungsten in a town
with known emission of airborne tungsten.
Tungsten emission in Sweet Home, Oregon,
began in November 2000, and tree-ring tung-
sten in cottonwoods near the emission source
increased at that time relative to comparison
towns in central Oregon. This test demon-
strated that dendrochemistry accurately
depicts tungsten availability, at least when
using cottonwoods. Therefore, dendro-
chemistry, especially when using cottonwood
trees, can be trusted to accurately depict tung-
sten availability in Fallon, Nevada, where tim-
ing of emission of tungsten particles is not
known with certainty.
The comparison of real interest was
between Fallon and other towns of west-cen-
tral Nevada. Tree-ring tungsten in Fallon was
not significantly different from that of other
towns of west central Nevada during the tree-
ring period centered on 1991 [Figure 4 in our
article (Sheppard et al. 2007c)], before the
onset of the leukemia cluster. During the tree-
ring period centered on 1995, corresponding
to just before the onset of the leukemia cluster,
Fallon tree-ring tungsten began trending
upward and was significantly higher than
Nevada comparison towns. During the follow-
ing two time periods, overlapping temporally
with the childhood leukemia cluster, Fallon
tree-ring tungsten continued trending upward
and remained higher than Nevada comparison
towns, with significance levels at or near
p = 0.05 (we provided p-values in place of error
bars), thus indicating the temporal correspon-
dence between elevated tungsten in Fallon and
the childhood leukemia cluster.
The Centers for Disease Control and
Prevention (CDC) conclusion that tungsten is
not mathematically associated with the
leukemia cases of Fallon (CDC 2003) is based
on case-comparison testing within Fallon. This
does not rule out that an underlying association
actually exists but is not detectable by the case-
comparison technique. Granted, no relation
was reported between leukemia and tungsten
exposure, but exposure to tungsten was found
to be community-wide, with levels being high
both in case children and families and in com-
parison children and families (CDC 2003). In
other words, there was little to no variability
in exposure at the community scale (i.e., most
everyone in Fallon has been exposed) but high
variability in onset of disease (i.e., some people
got leukemia but others have not). When
variability of an exposure is low relative to indi-
vidual susceptibility to a disease, genetic studies
are needed to identify gene polymorphisms that
might make sick children more susceptible to
effects of the exposure (Steinberg et al. 2007).
Our environmental research in Fallon has
followed an ecologic approach with the philos-
ophy that greater variability in exposure
between different towns is more important
than the minor variability in exposure within
communities (Sheppard et al. 2007a). The
entire town of Fallon has been compared envi-
ronmentally with other towns of west-central
Nevada. Multiple environmental indicators
have been used, such as outdoor airborne par-
ticulates (Sheppard et al. 2006), lichens
(Sheppard et al. 2007d), surface dust
(Sheppard et al. 2007b), and tree rings
(Sheppard et al. 2007c). These indicators
incorporate environmental conditions differ-
ently from one another, yet they have corrobo-
rated one another in showing that airborne
tungsten is elevated in Fallon relative to other
towns of west-central Nevada or the surround-
ing desert. Additionally, airborne tungsten par-
ticles in Fallon have been identified as
anthropogenic in origin, and not natural
(Sheppard et al. 2007e).
Even with this preponderance of evidence
showing spatial and temporal patterns of air-
borne tungsten in Fallon, we still have not
concluded in any of our reports on Fallon
that exposure to tungsten causes leukemia.
Quite the opposite: We have acknowledged
that environmental data alone cannot lead to
such a conclusion and that direct biomedical
testing is needed to establish a causal linkage
between tungsten and leukemia.
Years ago in an article on disease cluster
research, Shimkin (1965) stated that coopera-
tion of industrial management is needed to
identify and reduce environmental carcino-
gens. This comment still rings true today.
Kennametal Inc. (Fallon, NV) claims that it
supports research in Fallon aimed at under-
standing the childhood leukemia cluster there
(Goodale 2005), but its support is apparently
selective. We hereby encourage Kennametal to
engage in reasonable dialogue about research
in Fallon related to the childhood leukemia
cluster.
The authors declare they have no competing
financial interests.
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Correspondence
ERRATUM
The April 2008 Focus article [Environ
Health Perspect 116:A160–A167 (2008)]
includes a misprint. The first paragraph
under the subhead “How Much Is Enough?”
should read: “Gilchrest points out a problem
with the literature: ‘Everyone recommends
something different, depending on the stud-
ies with which they are most aligned. One
study reports an increased risk of prostate
cancer for men with 25(OH)D levels above
90 ng/mL, for example [in contrast with the
idea that more vitamin D is more protective
against cancer].’” EHP regrets the error.